Plasma derived medicinal products play a key and often unique role in the treatment of many acute and chronic pathologies.
Some of the pathologies treated with plasma-derived medicinal products
![infografica-1-dottore-small](https://www.italiaplasma.it/wp-content/uploads/2021/11/infografica-1-dottore-small.png)
At international level, we are witnessing an increase in their use for:
![ragazzo](https://www.italiaplasma.it/wp-content/uploads/2021/11/ragazzo.png)
Self-sufficiency rates of the plasma derived medicinal products
National data year 2023
Albumin
Antithrombin
Immunoglobulins for intravenous use
Immunoglobulin for subcutaneous use
Factor VIII
Factor VIII / Factor von Willebrand
S/D virus-inactivated plasma
Factor IX
3-Factor Prothrombin complex concentrates
Fibrinogen
*The value does not include Pentaglobin™
**100% of total demand for contract-manufactured products
Plasma provided to industry 2000-2023
For monthly tracking data click here
Source:
Adapted by the CNS on data sent by the fractionation Companies, January 2024
Italian Plasma sent to the industry by category
Apheresis plasmaRecovered plasma
Source:
Adapted by the CNS on data sent by the fractionation Companies, January 2024